In a new study, researchers examined four randomized controlled trials of belimumab (Benlysta®) to gain a better ...

Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...

The Lupus Foundation of America (LFA) is excited to announce Karen Costenbader is the recipient of the LFA’s 2024 Predict and Prevent Lupus Research grant.

Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Here’s a summary of the most ...

This Hispanic Heritage Month, we celebrate the strength, culture, and contribution of the Hispanic and Latino communities across the country. As we celebrate these vibrant communities, it’s also ...

The Lupus Foundation of America (LFA) created the Predict and Prevent Lupus Research grant in 2024 to support innovative research aimed at identifying people at high risk for lupus and ultimately ...

Use your power! Find your walk and register your team today. Fundraise We provide you with all the tools you need to fundraise for lupus research, support and education services all while earning ...

Karen Costenbader, MD, MPH, is a rheumatologist and translational epidemiologist, whose research has focused on translational and clinical studies and trials in systemic lupus erythematosus (lupus or ...

The unpredictability of lupus can be overwhelming at times, especially when attempting to navigate a maze-like healthcare system. It is important to know how to self-advocate by knowing your rights ...